GVK Biosciences acquires Aragen Bioscience

Posted By:
Subscribe to GoodReturns

GVK Biosciences acquires Aragen Bioscience
GVK Biosciences Pvt. Ltd., a leading Hyderabad-based small molecule contract research organization (CRO), announced the acquisition of Aragen Bioscience Inc., a privately-held US-based pre-clinical CRO that specializes in high-value biologics. The financial consideration of the deal was not disclosed GVK Biosciences

The development marks the company's first acquisition in the overseas market. Commenting on the acquisition the company said"This deal enables GVK Biosciences to expand its service offering to a broader base of organizations and gives GVK Bio expertise in biologics services and a significant US presence".

Further, through the acquisition, GVK Biosciences' gains know-how in large molecule R&D services together with a wide array of high-content biologics services. The acquisition will also strengthen the position of GVK as the major company providing integrated R&D services across small as well as large molecule platforms.


Read more about: pharma, gvk biosciences, acquisition
Story first published: Wednesday, January 29, 2014, 16:20 [IST]
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'